CME Courses - Coming Soon!

The Physician-Patient Alliance for Health & Safety would like to thank Inflammatix, Inc. for their unrestricted educational grant. Because of grants from Inflammatix and others, we are able to provide quality clinical educational content. 

Inflammatix, a pioneering molecular diagnostics company headquartered in Sunnyvale, California, USA, is developing novel diagnostics that rapidly read a patient’s immune system to improve patient care and reduce major public health burdens.

Please complete this form to be notified as soon as the Spotlight sessions are available for continuing medical education (CME) credits.